MedTrace Logo

Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy

NCT02310594 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 139

Last updated 2022-08-18

No results posted yet for this study

Summary

This research trial studies the effect of radiation therapy on tumor immunity. Standard radiation therapy destroys tumor cells. In response to tumor cell death caused by radiation therapy, the body has an ability to stimulate an anti-tumor response (immunity), but this response is often ineffective in shrinking tumor tissue. Collecting samples of blood from patients before, during, and after radiation therapy to study in the laboratory may help doctors learn more about the effects of radiation therapy on anti-tumor response.

Conditions

  • Malignant Neoplasm

Interventions

OTHER

cytology specimen collection procedure

Undergo blood sample collection

OTHER

laboratory biomarker analysis

Correlative studies

Sponsors & Collaborators

  • Jonsson Comprehensive Cancer Center

    lead OTHER

Principal Investigators

  • Michael Steinberg · Jonsson Comprehensive Cancer Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-07-08
Primary Completion
2022-08-09
Completion
2022-08-09

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02310594 on ClinicalTrials.gov